Marijuana is a Schedule I substance under the Controlled Substances Act, which means that it has a high potential for abuse, is not currently accepted for medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. Cannabis is a natural product, whose main psychoactive component is tetrahydrocannabinol (Δ9-THC). The cannabis plant (Cannabis sativa L. Along with tobacco, alcohol and caffeine, it is one of the most widely used drugs worldwide and has been used as a drug and source of fiber since historical times.
Herbal cannabis consists of the dried tips and leaves of flowers. Cannabis resin is a compressed solid made from the resinous parts of the plant, and cannabis oil (hashish) is a dissolving extract of cannabis. Cannabis is almost always smoked, often mixed with tobacco. Almost all consumption of herbs, cannabis and resin is illicit material.
Some therapeutic benefit as an analgesic has been claimed for cannabis, and dronabinol is a drug authorized in some countries for the treatment of nausea in cancer chemotherapy. Cannabis products and Δ9-THC are under international control. For many people, this is scandalous. Obviously, marijuana isn't as dangerous as heroin.
And it's no more dangerous than Schedule 2 drugs like cocaine and methamphetamine. So why the hell is time 1 of the pot? Schedule 1 drugs have no medical value and have a high potential for abuse, while Schedule 2 to 5 substances have some medical value, but differ in classification according to their potential for abuse (from highest to lowest). In general, Schedule 1 and Schedule 2 drugs have the most regulatory restrictions on research, supply, and access, and Schedule 5 drugs have the lowest quantity. But that doesn't necessarily mean that the federal government considers marijuana and heroin as equally dangerous drugs, or that it considers marijuana to be more dangerous than methamphetamine or cocaine.
The drugs in Schedules 1 and 2 are described as having a high potential for abuse, a vague description that does not classify drugs in the two categories as the same or different. The big difference between Schedule 1 and Schedule 2 substances, on the other hand, is whether the federal government thinks a drug has medical value. The DEA says Schedule 2 substances have some medical value and Schedule 1 substances do not, so the latter receive greater regulatory scrutiny even though they are not more dangerous. Schedule 1 and Schedule 2 Drugs Face Stricter Regulations.
Schedule 1 drugs are effectively illegal for anything outside of research, and Schedule 2 drugs can be used for limited medical purposes with DEA approval, for example, through a prescription drug license. The DEA even sets strict limits on the production of Schedule 1 and 2 drugs, although the limits vary from drug to drug. In the US, a University of Mississippi farm is currently allowed to grow marijuana under federal regulations, and the pot is limited for research purposes. In comparison, several private companies produce oxycodone, a Schedule 2 substance, and use the drug for prescription pain relievers.
A drug schedule can interfere with state laws. List 1 marijuana status is one of the reasons banks are reluctant to open accounts for marijuana stores and growers in Colorado and Washington, even though businesses are legal under state law. Federal tax law also prohibits businesses from deducting many expenses related to drug trafficking from schedules 1 and 2, which can cause effective income tax rates for state-owned marijuana companies to skyrocket to 90 percent. The two main recreational drugs that are not in the programming system, alcohol and tobacco, require a specific exemption in the Controlling Substances Act.
Mark Kleiman, an expert in drug policy, argues that both would be marked as program 1 if evaluated today, as they are widely used for recreational, addictive, harmful to health and society, and deadly purposes. When reviewing the classification of marijuana, its classification 1 status is consistently maintained due to insufficient scientific evidence of its medical value. But one reason that there is not enough scientific evidence to change the status of marijuana in list 1 could, in fact, be the status of the drug in list 1.The DEA restricts the amount of marijuana that can be used for research. To obtain legal marijuana supplies for studies, researchers must obtain approval of their studies from HHS, FDA, and DEA.
While a reclassification would be a symbolic victory for legalization advocates, Kleiman says it wouldn't have much practical effect. Schedule 2 substances generally require the distribution of a prescription, and the state's legal marijuana dispensaries and retail outlets don't work with traditional prescriptions (they distribute medical marijuana recommendations), so even rescheduling may not open access. Cocaine and methamphetamine are on Schedule 2, and they're definitely not readily available legally, after all. But the DEA hopes that its other steps will unlock much more research.
The Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) allows veterinarians to prescribe uses with additional labels of drugs approved for humans and animals for animals under certain conditions. Schedule 1 drugs have no medical value and have a high potential for abuse, while Schedule 2 to 5 substances have some medical value, but differ in classification according to their potential for abuse (from highest to lowest). Although retired, he serves as an inspector for the National Laboratory Certification Program and consults on drug abuse issues. Such products will not be considered a food or drug for the purposes of the “Colorado Food and Drug Act.”.
But the classification doesn't mean that the federal government thinks marijuana and heroin are equally dangerous drugs. FDA considers a substance to be authorized for research as a new drug if it is the subject of an effective investigational new drug (IND) request. Kleiman, who supports decriminalizing illicit drug use and legalizing marijuana, said an ideal replacement for the current programming system would also come with less stringent criminal penalties. There are exceptions, even when the drug was placed on the market in food before the drug was approved or before substantial clinical investigations related to the drug had been instituted or, in the case of animal feed, that the drug is a new animal medicine approved for use in feed and used in accordance with approved labeling.
This change can speed up the process for researchers to study cannabis and its derivatives, including CBD, that fall within the definition of hemp, which could accelerate the development of new drugs. To conduct clinical research that could lead to the approval of a new drug, including research with plant materials such as cannabis, researchers must work with the FDA and submit an IND request to the Center for Drug Evaluation and Research (CDER). Additional information on research on the medical use of cannabis is available from the National Institutes of Health, in particular the National Cancer Institute (NCI) and the National Institute on Drug Abuse (NIDA). The war on drugs began at a time when much of the nation was hysterical, so drugs such as marijuana and LSD would affect the moral fabric of the country.
. .
